Concepedia

Publication | Open Access

Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint

DOIFull Paper Access

27

Citations

33

References

2016

Year

Matthew T. Huggett, Slavica Tudzarova, Ian Proctor, Marco Loddo, Margaret G. Keane, Kai Stoeber, Gareth Williams, Stephen P. Pereira
Oncotarget

Abstract

Our findings show that Cdc7 is a potent anti-cancer target in pancreatic adenocarcinoma and that Cdc7 immunoexpression levels might be used as a companion diagnostic to predict response to therapeutic siRNAs or SMIs directed against this kinase.

References

YearCitations

Page 1